Prognosis
Pfizer Taps Brazil Producer to Expand Vaccines in Latin America
- Eurofarma signs deal to manufacture 100 million doses a year
- Agreement will bolster Latin America’s supply of vaccines
Residents line up for the Pfizer-BioNTech Covid-19 vaccine during a mass vaccination event on Paqueta Island, Rio de Janeiro state, Brazil.
Photographer: Maria Magdalena Arrellaga/BloombergThis article is for subscribers only.
Pfizer Inc. and BioNTech SE announced a deal with a Brazilian manufacturer to produce 100 million doses of their Covid-19 vaccine annually for Latin America.
Under the terms announced Thursday, the Brazilian pharmaceutical company Eurofarma Laboratorios SA will perform the so-called fill-and-finish process in which the vaccine is put into sterile vials.